Last A$18.12 AUD
Change Today -0.04 / -0.22%
Volume 1.3M
SHL On Other Exchanges
Symbol
Exchange
OTC US
Berlin
OTC US
As of 2:10 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

sonic healthcare ltd (SHL) Snapshot

Open
A$18.20
Previous Close
A$18.16
Day High
A$18.23
Day Low
A$18.06
52 Week High
05/13/14 - A$18.34
52 Week Low
07/30/13 - A$14.19
Market Cap
7.3B
Average Volume 10 Days
1.1M
EPS TTM
A$0.91
Shares Outstanding
400.8M
EX-Date
02/28/14
P/E TM
19.9x
Dividend
A$0.76
Dividend Yield
4.21%
Current Stock Chart for SONIC HEALTHCARE LTD (SHL)

Related News

No related news articles were found.

sonic healthcare ltd (SHL) Related Businessweek News

No Related Businessweek News Found

sonic healthcare ltd (SHL) Details

Sonic Healthcare Limited provides medical diagnostic services, and administrative services and facilities to medical practitioners. The company operates through Pathology, Radiology, and Other segments. It offers pathology/clinical laboratory services, and radiology and diagnostic imaging services to medical practitioners, hospitals, community health services, and their collective patients. The company also operates a network of primary care medical centers and independent practitioner network, as well as other healthcare businesses. It has operations in Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland. The company was formerly known as Sonic Technology Australia Limited and changed its name to Sonic Healthcare Limited in 1995. Sonic Healthcare Limited is headquartered in Macquarie Park, Australia.

26,000 Employees
Last Reported Date: 09/25/13

sonic healthcare ltd (SHL) Top Compensated Officers

Chief Executive Officer, Managing Director, E...
Total Annual Compensation: A$2.3M
Chief Financial Officer, Finance Director, Ex...
Total Annual Compensation: A$1.0M
Chairman of Sonic Imaging Executive Committee...
Total Annual Compensation: A$682.1K
Executive Director
Total Annual Compensation: A$346.5K
Compensation as of Fiscal Year 2013.

sonic healthcare ltd (SHL) Key Developments

Sonic Healthcare Limited Reports Earnings Results for the Quarter Ended December 31, 2013

Sonic Healthcare Limited reported earnings results for the quarter ended December 31, 2013. For the period, the company reported Sales revenue of AUD 1,898.7 million against AUD 1,677.5 million a year ago. Total revenue was AUD 1,898.7 million against AUD 1,697.3 million a year ago. Pre tax profit was AUD 235.4 million against AUD 202.3 million a year ago. Profit after tax was AUD 177.3 million against AUD 150.6 million a year ago. Return on equity was 5.8% against 5.6% a year ago. EPS was up 15.8% from AUD 0.38 to AUD 0.44 a year ago.

Sonic Healthcare Seeks Acquisitions

Sonic Healthcare Limited (ASX:SHL) seeks acquisitions. "We continue to seek out synergistic acquisitions, and I believe Germany is probably our most suitable and fruitful market," Sonic Chief Executive Colin Goldschmidt said. "It (the German pathology market) remains fragmented, and it's a country where I believe we offer significant product differentiation." Goldschmidt said Sonic was gaining market share in Germany, winning new hospital contracts and undertaking various growth initiatives. Shares in Sonic were nine cents, or 0.53%, lower at AUD 16.89.

Sonic Healthcare Limited Announces Interim Dividend, Payable on March 25, 2014; Announces Earnings Results for the Half Year Ended December 31, 2013; Provides Earnings Guanidine for the Year 2014

Sonic Healthcare Limited announced increased interim dividend by 8% to 27 cents per share, 45% franked. Record date is March 6, 2014 and payable date is on March 25, 2014. The company announced earnings results for the half year ended December 31, 2013. For the period, the company reported revenue of AUD 1,772 million, increased by 4.4% compared to prior year. EBITDA was AUD 321 million, increased by 5.6% compared to prior year. Net profit was AUD 165 million, increased by 9.6% compared to prior year. EPS was 39.5 cents, up 8% on prior year. The result was achieved on revenues of AUD 1,898 million, 11.9% higher than the corresponding period. On statutory basis, the company’s revenue was AUD 1,899 million, increased by 11.9% compared to prior year. EBITDA was AUD 344 million, increased by 13.4% compared to prior year. Net profit was AUD 177 million, increased by 17.7% compared to prior year. For 2014, net interest expense is expected to decrease by approximately 15% from the 2013 level of AUD 63 million on a constant currency basis. Effective tax rate for 2014 is expected to be approximately 25%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHL:AU A$18.12 AUD -0.04

SHL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Genetic Technologies Ltd A$0.03 AUD 0.00
View Industry Companies
 

Industry Analysis

SHL

Industry Average

Valuation SHL Industry Range
Price/Earnings 21.1x
Price/Sales 2.1x
Price/Book 2.5x
Price/Cash Flow 14.9x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SONIC HEALTHCARE LTD, please visit www.sonichealthcare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.